$44MSeries C, 12 August 2025
Funds complete the Phase 3 trial of Fertilo and global regulatory filings.
- Amount
- $44M
- Stage
- Series C
- Announced
- 12 August 2025
- Lead
- Overwater Ventures
- Other investors
- Insight Partners, RA Capital, Two Sigma Ventures
- Use of funds
- Funds complete the Phase 3 trial of Fertilo and global regulatory filings.
- Checked
- Announced by the company
- Sources
- Gameto raises $44M Series C for stem cell therapies in reproductive health biospace.com
Gameto raises $44M Series C for stem cell therapies in reproductive health alleywatch.com